APA (7th ed.) Citation

Maher, V. E., Fernandes, L. L., Weinstock, C., Tang, S., Agarwal, S., Brave, M., . . . Pazdur, R. (2019). Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody. Journal of clinical oncology, 37(30), JCO1900318. https://doi.org/10.1200/JCO.19.00318

Chicago Style (17th ed.) Citation

Maher, V Ellen, et al. "Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody." Journal of Clinical Oncology 37, no. 30 (2019): JCO1900318. https://doi.org/10.1200/JCO.19.00318.

MLA (9th ed.) Citation

Maher, V Ellen, et al. "Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody." Journal of Clinical Oncology, vol. 37, no. 30, 2019, p. JCO1900318, https://doi.org/10.1200/JCO.19.00318.